iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://pubmed.ncbi.nlm.nih.gov/19236314
Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2009 Apr;119(4):252-65.
doi: 10.1111/j.1600-0447.2008.01326.x. Epub 2008 Feb 18.

Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies

A J Mitchell  1 , M Shiri-Feshki
Affiliations
Meta-Analysis

Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies

A J Mitchell et al. Acta Psychiatr Scand. 2009 Apr.

Abstract

Objective: To quantify the risk of developing dementia in those with mild cognitive impairment (MCI).

Method: Meta-analysis of inception cohort studies.

Results: Forty-one robust cohort studies were identified. To avoid heterogeneity clinical studies, population studies and clinical trials were analysed separately. Using Mayo defined MCI at baseline and adjusting for sample size, the cumulative proportion who progressed to dementia, to Alzheimer's disease (AD) and to vascular dementia (VaD) was 39.2%, 33.6% and 6.2%, respectively in specialist settings and 21.9%, 28.9% and 5.2%, respectively in population studies. The adjusted annual conversion rate (ACR) from Mayo defined MCI to dementia, AD and VaD was 9.6%, 8.1% and 1.9%, respectively in specialist clinical settings and 4.9%, 6.8% and 1.6% in community studies. Figures from non-Mayo defined MCI and clinical trials are also reported.

Conclusion: The ACR is approximately 5-10% and most people with MCI will not progress to dementia even after 10 years of follow-up.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types

LinkOut - more resources